Transcriptional profiling studies comparing the total brains of RTT patients or mouse models with controls have revealed only subtle differences in gene expression dampening a role for MeCP2 as a global regulator of transcription (Chadwick and Wade, 2007). The gene discussed is MECP2; the disease is Rett syndrome.